OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 150 filers reported holding OCULAR THERAPEUTIX INC in Q2 2021. The put-call ratio across all filers is 0.38 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $99,654 | -39.1% | 31,737 | 0.0% | 0.00% | – |
| Q2 2023 | $163,763 | -1.5% | 31,737 | +0.6% | 0.00% | – |
| Q1 2023 | $166,205 | +87.5% | 31,538 | 0.0% | 0.00% | – |
| Q4 2022 | $88,622 | -33.1% | 31,538 | -1.2% | 0.00% | – |
| Q3 2022 | $132,431 | -0.1% | 31,911 | -3.3% | 0.00% | – |
| Q2 2022 | $132,612 | -18.7% | 32,988 | +0.1% | 0.00% | – |
| Q1 2022 | $163,132 | -43.7% | 32,956 | -20.9% | 0.00% | – |
| Q4 2021 | $290,000 | -28.9% | 41,653 | +2.2% | 0.00% | – |
| Q3 2021 | $408,000 | -34.2% | 40,772 | -6.8% | 0.00% | -100.0% |
| Q2 2021 | $620,000 | -7.7% | 43,740 | +6.8% | 0.00% | 0.0% |
| Q1 2021 | $672,000 | -20.5% | 40,947 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $845,000 | +221.3% | 40,819 | +18.2% | 0.00% | – |
| Q3 2020 | $263,000 | +0.8% | 34,521 | +9.3% | 0.00% | – |
| Q2 2020 | $261,000 | +83.8% | 31,577 | +10.4% | 0.00% | – |
| Q1 2020 | $142,000 | +31.5% | 28,608 | +4.3% | 0.00% | – |
| Q4 2019 | $108,000 | +22.7% | 27,435 | +0.4% | 0.00% | – |
| Q3 2019 | $88,000 | -26.7% | 27,325 | +0.1% | 0.00% | – |
| Q2 2019 | $120,000 | +14.3% | 27,285 | +2.9% | 0.00% | – |
| Q1 2019 | $105,000 | +123.4% | 26,519 | +123.8% | 0.00% | – |
| Q4 2018 | $47,000 | -74.2% | 11,852 | -55.2% | 0.00% | – |
| Q3 2018 | $182,000 | -2.7% | 26,458 | -4.7% | 0.00% | – |
| Q2 2018 | $187,000 | +19.1% | 27,759 | +15.1% | 0.00% | – |
| Q1 2018 | $157,000 | +528.0% | 24,123 | +328.4% | 0.00% | – |
| Q4 2017 | $25,000 | +212.5% | 5,631 | +317.7% | 0.00% | – |
| Q3 2017 | $8,000 | -95.4% | 1,348 | -92.8% | 0.00% | – |
| Q2 2017 | $174,000 | +24.3% | 18,739 | +24.2% | 0.00% | – |
| Q1 2017 | $140,000 | +28.4% | 15,089 | +15.6% | 0.00% | – |
| Q4 2016 | $109,000 | +172.5% | 13,052 | +122.9% | 0.00% | – |
| Q3 2016 | $40,000 | +900.0% | 5,855 | +672.4% | 0.00% | – |
| Q2 2016 | $4,000 | -96.2% | 758 | -93.2% | 0.00% | – |
| Q1 2016 | $105,000 | +9.4% | 11,183 | +8.9% | 0.00% | – |
| Q4 2015 | $96,000 | -33.3% | 10,270 | 0.0% | 0.00% | – |
| Q3 2015 | $144,000 | -24.2% | 10,270 | +13.5% | 0.00% | – |
| Q2 2015 | $190,000 | -2.6% | 9,049 | +94.5% | 0.00% | – |
| Q1 2015 | $195,000 | +413.2% | 4,652 | +189.5% | 0.00% | – |
| Q4 2014 | $38,000 | – | 1,607 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |